Company Data
Avalo Therapeutics Inc.
Ticker
AVTX
Current Price
$11.27 -6.16%
Market Cap
$604.4M
Price Target
Refer to Report
Volume
969.4K
52wk Range
$11.58 - $24.27
Overview
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006.